LY353381 in Preventing Breast Cancer in Women With Hyperplasia
Status:
Completed
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the
development or recurrence of cancer. The use of LY353381 may be an effective way to prevent
the development of breast cancer in women who have hyperplasia.
PURPOSE: Randomized phase II trial to study the effectiveness of LY353381 in preventing
breast cancer in women who have hyperplasia.